TABLE 3.
Management of severe postpartum hemorrhage in women with peripartum hysterectomy according to cause
| All causes n = 42 | Atony aloneas cause n = 13 | PAS as cause n = 22 | |
|---|---|---|---|
| n (%) | n (%) | n (%) | |
| Medications | |||
| Prophylactic oxytocin | 36 (85.7) | 13 (100) | 18 (81.8) |
| Oxytocin infusion | 28 (66.7) | 12 (92.3) | 11 (50.0) |
| Prostaglandins | 15 (35.7) | 10 (76.9) | 2 (9.1) |
| Ergometrin | 7 (16.7) | 2 (15.4) | 3 (13.6) |
| Tranexamic acid | 21 (50.0) | 8 (61.5) | 9 (40.9) |
| Surgical procedures | |||
| Curettage | 7 (16.7) | 3 (23.1) | 3 (13.6) |
| Intrauterine balloon | 12 (28.6) | 6 (46.2) | 5 (22.7) |
| Uterine suture | 6 (14.3) | 1 (7.7) | 3 (13.6) |
| Ligation of uterine arteries | 5 (11.9) | 3 (23.1) | 1 (4.5) |
| Embolization of pelvic arteries | 9 (21.4) | 5 (38.5) | 2 (9.1) |
| REBOA | 9 (21.4) | 1 (7.7) | 7 (31.8) |
| Transfusion of blood products | |||
| Red blood cells ≥8 units | 26 (61.9) | 9 (69.2) | 11 (50.0) |
| Red blood cells ≥12 units | 16 (38.1) | 4 (30.8) | 8 (36.4)) |
| Plasma ≥8 units a | 15 (35.7) | 4 (30.8) | 7 (31.8) |
PAS, placenta accrete spectrum disorders; REBOA, resuscitative endovascular balloon occlusion of aorta.
a
One missing.